cnspharma.com - היקף יתרות המזומנים של החברה CNSP

סמלים רשמיים של חברת CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals management is aggressively developing targeted brain tumor therapy across Western clinics. The cash balance helps assess the issuer's liquidity, while the 0.02 level captures the current state. High-tech bioscreening accelerates the search for drug formulas, and a stable core of managers is implementing international adaptive trials with operational precision.

CNSP - היקף יתרות המזומנים של החברה CNS Pharma בטווח 04.07.2022 - 21.11.2026

פילוחי מדדים ואנליטיקה של חברת CNS Pharmaceuticals, Inc. (CNSP)

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח מקיף של החברה:cnspharma.com
מוצר ממותג של cnspharma.com

The metric's dynamics are determined by the difference between operating cash flows and current expenses. This indicator captures the volume of liquid assets that ensure solvency without external borrowing. For CNS Pharmaceuticals (CNSP), capital is critically important when implementing ESG standards and maintaining strict bioethical compliance in brain cancer therapy. These expenditures require stable funding. By analyzing the free cash flow figure, an investor assesses the company's margin of safety.

מתחרים של CNS Pharmaceuticals